login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
GOODRX HOLDINGS INC-CLASS A (GDRX) Stock News
USA
-
Nasdaq
- NASDAQ:GDRX -
US38246G1085
-
Common Stock
2.75
USD
-0.03 (-1.08%)
Last: 12/18/2025, 12:10:40 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GDRX Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: GoodRx Holdings, Inc.
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference
2 days ago - By: Zacks Investment Research
- Mentions:
HIMS
TEM
Hims & Hers Scales Technology-Driven Care as Profitability Evolves
a month ago - By: Benzinga
- Mentions:
KURA
SEE
HRMY
FOLD
...
Earnings Scheduled For November 4, 2025
2 months ago - By: Stocktwits
GoodRx Stock Buzzes As TrumpRx Drug Pricing Shake-Up Draws BofA Warning On Core Business Model
2 months ago - By: Stocktwits
- Mentions:
AMGN
Amgen To Sell Cholesterol Drug For Approximately 60% Discount
9 days ago - By: Zacks Investment Research
- Mentions:
TDOC
HIMS
Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell?
20 days ago - By: Zacks Investment Research
- Mentions:
HIMS
HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside?
a month ago - By: Zacks Investment Research
- Mentions:
HIMS
DOCS
Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model
a month ago - By: Benzinga
- Mentions:
COST
NVO
LFMD
Novo Nordisk Leans Into Affordability Amid Rising Competition
a month ago - By: GoodRx
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®
a month ago - By: Zacks Investment Research
Here's What Key Metrics Tell Us About GoodRx (GDRX) Q3 Earnings
a month ago - By: Zacks Investment Research
- Mentions:
DCGO
GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings Estimates
a month ago - By: GoodRx Holdings, Inc.
GoodRx Reports Third Quarter 2025 Results
2 months ago - By: Zacks Investment Research
- Mentions:
MED
HIMS
Hims & Hers Scales AI-Driven Personalized Health and Wellness
2 months ago - By: GoodRx
GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment
2 months ago - By: GoodRx Holdings, Inc.
GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call
2 months ago - By: GoodRx
GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings
3 months ago - By: GoodRx
GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy
Please enable JavaScript to continue using this application.